Has participated in:
-
TRAIL-based multivalent and multifunctional fusion proteins and liposomes for therapeutic applications
-
Db-Igs — eine Plattform zur Herstellung multispezifischer Antikörper
-
A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells
-
GlycoTAIL and FlexiTAIL as half-life extension modules for recombinant antibody fragments